HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China FDA Reforms Are “Good News” For Foreign Firms … Probably

This article was originally published in The Rose Sheet

Executive Summary

Registration of imported ordinary-use cosmetics will now be administered by China Food and Drug Administration at a provincial level, which could speed the registration process, according to April Guo, regulatory affairs specialist for consulting firm CIRS’s China division. She acknowledges, however, that challenges could arise.

You may also be interested in...



PCPC Steps Up Diplomacy As China Eyes Broad Regulatory Reform

Ahead of an expected overhaul of China’s cosmetics regulations, the Personal Care Products Council is working closely with Chinese regulators, pushing for greater harmonization with regulations in the U.S. and other countries. Meanwhile, stakeholders must content themselves with piecemeal updates to China’s existing regulatory framework for cosmetics.

PCPC Steps Up Diplomacy As China Eyes Broad Regulatory Reform

Ahead of an expected overhaul of China’s cosmetics regulations, the Personal Care Products Council is working closely with Chinese regulators, pushing for greater harmonization with regulations in the U.S. and other countries. Meanwhile, stakeholders must content themselves with piecemeal updates to China’s existing regulatory framework for cosmetics.

Victor In China’s Cosmetic-Ingredient Approval Process Tells His Story

Navigating China’s notoriously challenging registration process for new cosmetic ingredients requires a local representative who can respond quickly to CFDA’s questions before the evaluation committee membership changes and sends firms back to square one. A former Symrise exec offers insight into the process and how the supplier successfully won approval for its SymWhite 377 brightening agent.

UsernamePublicRestriction

Register

RS018567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel